Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pharmaceutical composition and its application

A composition and drug technology, applied to the pharmaceutical composition and its application field, can solve problems such as abnormal blood lipid metabolism, and achieve the effects of reducing serum cholesterol, improving cardiac function ejection fraction, and preventing and treating cardiovascular and cerebrovascular diseases.

Active Publication Date: 2021-02-23
GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a pharmaceutical composition and its application, which aims to improve the existing problem of abnormal blood lipid metabolism

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pharmaceutical composition and its application
  • A kind of pharmaceutical composition and its application
  • A kind of pharmaceutical composition and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] This embodiment provides a pharmaceutical composition, which mainly consists of total saponins of Astragalus and volatile oil of Angelica sinensis. Among them, the mass ratio of the total saponins of Astragalus and the volatile oil of Angelica sinensis is 16.8:5.9.

Embodiment 2

[0055] This embodiment provides a pharmaceutical composition, which mainly consists of total saponins of Astragalus and volatile oil of Angelica sinensis. Among them, the mass ratio of astragalus total saponins to angelica volatile oil is 17.5:5.9.

Embodiment 3

[0057] This embodiment provides a pharmaceutical composition, which mainly consists of total saponins of Astragalus and volatile oil of Angelica sinensis. Among them, the mass ratio of the total saponins of Astragalus and the volatile oil of Angelica sinensis is 17.2:5.9.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the pharmaceutical field, and in particular relates to a pharmaceutical composition and the use thereof. Disclosed is a pharmaceutical composition, mainly comprising a first component and a second component, wherein the first component is a total saponin of astragalus, and the second component is a volatile oil of Angelica sinensis; or the first component is astragaloside, and the second component is ferulic acid. Also disclosed is the use of the above-mentioned pharmaceutical composition in the preparation of a drug for preventing and / or treating atherosclerosis. The pharmaceutical composition has significant effects on decreasing serum cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and serum triglyceride, and increasing cardiac function and the ejection fraction; and hence the pharmaceutical composition has the effect of preventing or treating hyperlipemia, so as to further prevent and treat atherosclerosis and cardiovascular and cerebrovascular diseases.

Description

technical field [0001] The present invention relates to the field of medicines, in particular to a pharmaceutical composition and its application. Background technique [0002] With the change of people's lifestyle, more and more high-protein, high-cholesterol, and high-sugar foods are consumed, which leads to an obvious upward trend in the incidence of hyperlipidemia. Hyperlipidemia refers to high total cholesterol (TC) and / or triglyceride (TG) or low high-density lipoprotein cholesterol (HDL-C) in the blood. Clinically divided into: hypercholesterolemia (increased serum TC), hypertriglyceridemia (increased serum TG), mixed hyperlipidemia (increased TC, TG), low high-density lipoprotein Hyperemia (decreased serum HDL-C levels). [0003] Hyperlipidemia is the prerequisite for the formation of atherosclerosis, and there is a clear correlation with the incidence of cardiovascular and cerebrovascular diseases. Therefore, in the prevention and treatment of cardiovascular and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/192A61K31/7048A61K36/481A61P3/06A61P9/10A61P9/00
CPCA61K31/192A61K31/7048A61K36/232A61K36/481A61K2300/00
Inventor 黄水清
Owner GUANGZHOU UNIVERSITY OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com